Skip to main content
. Author manuscript; available in PMC: 2024 Feb 23.
Published in final edited form as: Resuscitation. 2023 May 29;188:109855. doi: 10.1016/j.resuscitation.2023.109855

Table 2 –

Outcomes of hospital survivors and non-survivors.

Variable Survivors
n = 83		 Non-survivors
n = 108		 p
Length of ECMO, median (IQR), hours 93 (59–151) 69 (29–141) 0.081
ECMO flow 1 hour after cannulation, median (IQR), ml/kg/min 105 (84–142) 102 (77–147) 0.512
VIS 1 hour after cannulation, median (IQR) 2.5 (0–5) 3 (0–8) 0.11
Vasodilator use, n (%) 41 (49) 30 (28) 0.002
Any AKIa, n (%) 36 (49) 67 (71) 0.004
AKI stage 3a, n (%) 10 (14) 33 (35) 0.002
Favorable neurologic outcomeb, n (%) 62 (77) NA NA
Brain death NA 25 (23) NA
Hypoxic ischemic encephalopathy 14 (17) 24 (22) 0.358
a.

Kidney function not available in all patients, n = 169.

b.

Survivors, n = 81.

AKI, acute kidney injury; ECMO, extracorporeal membrane oxygenation; VIS, vasoactive-inotropic score.